Oncocyte Corp entered into a Merger Agreement with Chronix, completed on April 15, 2021, and terminated a Collaboration Agreement with Life Technologies Corporation on February 7, 2023. They also received a notice of delisting from Nasdaq and transferred their listing to The Nasdaq Capital Market.